Arbor Realty (ABR) rated Sell: worsening losses, rising credit costs, and refinancing risk threaten dividends.
This announcement contains inside information14 September 2026Update on SERENA-4 Phase III trial of Etcamah in combination with palbociclib in upfront 1st-line advanced ER-positive breast cancer SEREN ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results